Summit Global Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-36,238
| Closed | -$1.67M | – | 506 |
|
|
2023
Q3 | $1.67M | Buy |
36,238
+16,394
| +83% | +$754K | 0.11% | 143 |
|
|
2023
Q2 | $1.14M | Sell |
19,844
-17,456
| -47% | -$1M | 0.08% | 199 |
|
|
2023
Q1 | $1.4M | Buy |
37,300
+7,800
| +26% | +$293K | 0.11% | 177 |
|
|
2022
Q4 | $827K | Buy |
29,500
+9,400
| +47% | +$264K | 0.07% | 229 |
|
|
2022
Q3 | $565K | Sell |
20,100
-33,114
| -62% | -$931K | 0.05% | 286 |
|
|
2022
Q2 | $1.85M | Buy |
53,214
+8,514
| +19% | +$296K | 0.16% | 140 |
|
|
2022
Q1 | $1.61M | Sell |
44,700
-1,200
| -3% | -$43.1K | 0.12% | 173 |
|
|
2021
Q4 | $1.07M | Sell |
45,900
-14,600
| -24% | -$340K | 0.07% | 225 |
|
|
2021
Q3 | $1.15M | Buy |
60,500
+13,100
| +28% | +$249K | 0.09% | 185 |
|
|
2021
Q2 | $956K | Sell |
47,400
-146
| -0.3% | -$2.95K | 0.06% | 239 |
|
|
2021
Q1 | $871K | Sell |
47,546
-14,833
| -24% | -$272K | 0.06% | 220 |
|
|
2020
Q4 | $1.25M | Sell |
62,379
-613
| -1% | -$12.3K | 0.13% | 131 |
|
|
2020
Q3 | $1.18M | Buy |
62,992
+552
| +0.9% | +$10.3K | 0.12% | 118 |
|
|
2020
Q2 | $1.4M | Buy |
62,440
+3,800
| +6% | +$85.3K | 0.16% | 91 |
|
|
2020
Q1 | $870K | Buy |
58,640
+9,600
| +20% | +$142K | 0.13% | 99 |
|
|
2019
Q4 | $946K | Buy |
49,040
+6,315
| +15% | +$122K | 0.1% | 138 |
|
|
2019
Q3 | $847K | Buy |
+42,725
| New | +$847K | 0.1% | 167 |
|